291 related articles for article (PubMed ID: 23959519)
1. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.
Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M
J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519
[TBL] [Abstract][Full Text] [Related]
2. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
[TBL] [Abstract][Full Text] [Related]
3. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
Kogelnik AM; Loomis K; Hoegh-Petersen M; Rosso F; Hischier C; Montoya JG
J Clin Virol; 2006 Dec; 37 Suppl 1():S33-8. PubMed ID: 17276366
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.
Hierro L; Díez-Dorado R; Díaz C; De la Vega A; Frauca E; Camarena C; Muñoz-Bartolo G; González de Zárate A; López Santamaría M; Jara P
Liver Transpl; 2008 Aug; 14(8):1185-93. PubMed ID: 18668670
[TBL] [Abstract][Full Text] [Related]
6. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
[TBL] [Abstract][Full Text] [Related]
7. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W
Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
9. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
11. Human Placental Extract as a Subcutaneous Injection Is Effective in Chronic Fatigue Syndrome: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
Park SB; Kim KN; Sung E; Lee SY; Shin HC
Biol Pharm Bull; 2016 May; 39(5):674-9. PubMed ID: 26911970
[TBL] [Abstract][Full Text] [Related]
12. Lessons from a pilot study of transfer factor in chronic fatigue syndrome.
De Vinci C; Levine PH; Pizza G; Fudenberg HH; Orens P; Pearson G; Viza D
Biotherapy; 1996; 9(1-3):87-90. PubMed ID: 8993764
[TBL] [Abstract][Full Text] [Related]
13. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
Bounaadja L; Piret J; Goyette N; Boivin G
J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers.
Boonsopon S; Maghsoudlou A; Kombo NE; Foster CS
Eur J Ophthalmol; 2016; 26(1):30-5. PubMed ID: 26350994
[TBL] [Abstract][Full Text] [Related]
15. [Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].
Nishikai M
Nihon Rinsho; 1992 Nov; 50(11):2641-7. PubMed ID: 1337560
[TBL] [Abstract][Full Text] [Related]
16. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
[TBL] [Abstract][Full Text] [Related]
18. (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.
Höcker B; Böhm S; Fickenscher H; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Feneberg R; Köpf-Shakib S; Tönshoff B
Transpl Int; 2012 Jul; 25(7):723-31. PubMed ID: 22533698
[TBL] [Abstract][Full Text] [Related]
19. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I; Len O; de la Cámara R; Gurguí M; Martino R; Jarque I; Barrenetxea C; Díaz de Heredia C; Batlle M; Rovira M; de la Torre J; Torres A; Aguilar M; Espigado I; Martín-Dávila P; Bou G; Borrell N; Aguado JM; Pahissa A;
Antivir Ther; 2011; 16(7):951-7. PubMed ID: 22024510
[TBL] [Abstract][Full Text] [Related]
20. Valganciclovir for the Suppression of Epstein-Barr Virus Replication.
Yager JE; Magaret AS; Kuntz SR; Selke S; Huang ML; Corey L; Casper C; Wald A
J Infect Dis; 2017 Jul; 216(2):198-202. PubMed ID: 28838145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
